US tariffs won't hurt Indian pharma and steel exports: Tycoons

Indian pharmaceutical and steel sectors show resilience against proposed US trade tariffs. Sun Pharma's Shanghvi indicates limited impact on the pharma industry due to critical healthcare needs. Meanwhile, Jindal Steel's Jindal reveals India's strong domestic steel consumption may mitigate the effects of the 25% tariffs on imported steel.